Abstract
IntroductionWe have identified a cohort of injection drug users (IDU) who, despite long-term high risk sharing of drug injection equipment, remain seronegative and aviraemic for HCV. These exposed uninfected (EU)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
